OFS Capital Corp. Q1 2015 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2015. OFS Capital Corp. is an externally managed, closed-end, non-diversified management investment company operating as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company focuses on debt and equity investments in middle-market U.S. companies. It operates through two primary subsidiaries: OFS Capital WM (a credit facility vehicle) and SBIC I LP (a Small Business Investment Company licensed by the SBA).
Key Financial Metrics
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Total Investment Income | $7.62 million | $5.01 million |
| Net Investment Income | $2.75 million | $1.40 million |
| Net Increase in Net Assets (Operations) | $3.23 million | $2.05 million |
| Net Asset Value (NAV) per Share | $14.24 | $14.45 |
| Market Value per Share | $12.25 | $12.51 |
| Total Assets | $347.31 million | $341.48 million |
| Total Liabilities | $209.74 million | $204.01 million |
| Cash and Cash Equivalents | $21.30 million | $12.45 million |
| Debt Outstanding (SBA Debentures) | $140.88 million | $127.30 million |
| Debt Outstanding (Revolving Credit) | $64.35 million | $72.61 million |
Material Changes vs. Prior Period
- Revenue Growth: Total investment income increased 52% to $7.62 million, driven primarily by higher interest income from SBIC I LP investments and increased dividend/fee income from preferred equity.
- Expense Increase: Total expenses rose 35% to $4.87 million. This was due to a $0.38 million incentive fee (none in Q1 2014), higher interest expense on SBA debentures, and a $0.43 million write-off of deferred financing costs following a permanent reduction of the revolving credit facility from $100 million to $75 million.
- Portfolio Composition: The portfolio fair value grew to $316.2 million. The company held 58 portfolio companies, with 79% in senior secured loans and 21% in subordinated loans. Equity investments represented 7% of the portfolio.
- Liquidity: Cash and cash equivalents increased by $8.85 million to $21.30 million, supported by net cash provided by operating activities ($7.01 million) and financing activities ($1.84 million).
Guidance, Outlook, and Risks
- Dividends: The Board declared a quarterly distribution of $0.34 per share for Q1 2015. Approximately 79% of the distribution was estimated as ordinary income and 21% as a return of capital. A subsequent Q2 2015 distribution of $0.34 per share was declared on May 4, 2015.
- Capital Deployment: The company has $7.6 million in unfunded commitments. It filed an application with the SBA for a second SBIC license in January 2015, which could provide up to $75 million in additional debentures if approved.
- Valuation Risks: Approximately 91% of assets are Level 3 investments valued using unobservable inputs (discounted cash flow models). Management notes that fair values may differ significantly from values in a liquid market.
- Regulatory Compliance: The company must maintain RIC status by distributing at least 90% of taxable income and comply with BDC asset coverage ratios. It also faces SBA regulatory oversight regarding its SBIC subsidiary.
Investor Verification Checklist
- Debt Leverage: Verify the impact of the $140.88 million SBA debentures and $64.35 million revolving credit facility on the company's asset coverage ratio and interest expense sensitivity.
- Non-Accrual Status: Confirm the status of the single non-accrual loan (Strata Pathology Services, Inc.), which had a fair value of $0.71 million.
- Valuation Methodology: Review the assumptions used for Level 3 fair value measurements, specifically discount rates and EBITDA multiples, given the lack of active market pricing.
- Second SBIC License: Monitor the status of the pending SBA application for a second license, which is critical for future capital deployment.
- Return of Capital: Assess the sustainability of distributions given that a portion (21% in Q1) was classified as a return of capital.